Frequently Asked Questions - IRB Registration: Guidance for Institutional Review Boards (IRBs)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 9, 2009
July 21, 2021
7a3de4e3-164a-476e-983c-437126be73f7
Related Documents
Process for Handling Referrals to FDA Under 21 CFR 5054 - Additional Safeguards for Children in Clinical Investigations: Guidance for Clinical Investigators, Institutional Review Boards and Sponsors
Guidance DocumentDecember 1, 2006Office of the Commissioner
180-Day Exclusivity When Multiple ANDAs Are Submitted on the Same Day
Guidance DocumentJuly 1, 2003Center for Drug Evaluation and Research
Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials: Guidance for Sponsors, Clinical Investigators, and IRBs
Guidance DocumentOctober 1, 2008Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.